Smith & Nephew SNATS ROE 2006-2018 | SNN

Current and historical return on equity (ROE) values for Smith & Nephew SNATS (SNN) over the last 10 years.
Smith & Nephew SNATS Annual ROE - Return on Equity
2017 16.52
2016 19.81
2015 10.34
2014 12.40
2013 13.74
2012 17.48
2011 20.84
2010 23.59
2009 26.62
2008 29.02
2007 26.43
2006 19.42
2005 25.81
Smith & Nephew SNATS Quarterly ROE - Return on Equity
Q2 2018 0.00
Q4 2017 0.00
Q2 2017 0.00
Q4 2016 0.00
Q4 2015 0.00
Q2 2015 0.00
Q4 2014 3.96
Q3 2014 2.54
Q2 2014 2.14
Q1 2014 3.56
Q4 2013 4.00
Q3 2013 3.12
Q2 2013 3.31
Q1 2013 3.62
Q4 2012 3.66
Q3 2012 3.68
Q2 2012 8.21
Q1 2012 4.66
Q4 2011 4.39
Q3 2011 4.35
Q2 2011 4.88
Q1 2011 5.20
Q4 2010 6.56
Q3 2010 5.53
Q2 2010 5.93
Q1 2010 7.14
Q4 2009 5.87
Q3 2009 6.37
Q2 2009 6.28
Q1 2009 5.74
Q4 2008 6.77
Q3 2008 4.18
Q2 2008 5.70
Q1 2008 4.60
Q4 2007 5.56
Q3 2007 0.68
Q2 2007 5.15
Q1 2007 4.22
Q4 2006 5.57
Q3 2006 4.49
Q2 2006 4.97
Q1 2006 4.61
Q4 2005 5.10
Q3 2005 4.00
Q2 2005 6.84
Q1 2005 6.50
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.491B $4.765B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $123.073B 19.05
Abbott Laboratories (ABT) United States $111.627B 23.39
Stryker (SYK) United States $62.161B 24.02
Boston Scientific (BSX) United States $46.605B 24.25
Baxter (BAX) United States $37.778B 25.71
Zimmer Biomet Holdings (ZBH) United States $24.903B 16.00
ResMed (RMD) United States $15.453B 30.67
Bio-Rad Laboratories (BIO) United States $9.687B 62.27
Perrigo (PRGO) Ireland $9.503B 13.48
Hill-Rom Holdings (HRC) United States $6.289B 21.33
ICU Medical (ICUI) United States $6.001B 40.67
Canopy Growth (CGC) Canada $5.429B 0.00
Haemonetics (HAE) United States $5.340B 48.73
Insulet (PODD) United States $5.133B 0.00
Agios Pharmaceuticals (AGIO) United States $4.525B 0.00
Neogen (NEOG) United States $4.386B 69.89
Hutchison China MediTech (HCM) China $4.128B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.707B 0.00
NuVasive (NUVA) United States $3.433B 32.57
National Vision Holdings (EYE) United States $3.287B 72.72
Quidel (QDEL) United States $2.771B 56.77
Phibro Animal Health (PAHC) United States $2.014B 29.91
NxStage Medical (NXTM) United States $1.858B 0.00
Cardiovascular Systems (CSII) United States $1.239B 745.00
Eagle Pharmaceuticals (EGRX) United States $1.195B 35.27
VAREX IMAGING (VREX) United States $1.118B 18.26
AtriCure (ATRC) United States $1.092B 0.00
Omeros (OMER) United States $1.001B 0.00
Orthofix (OFIX) United States $1.001B 30.48
OraSure Technologies (OSUR) United States $0.995B 65.08
TG Therapeutics (TGTX) United States $0.977B 0.00
Surmodics (SRDX) United States $0.976B 117.90
Cerus (CERS) United States $0.974B 0.00
Owens & Minor (OMI) United States $0.947B 10.13
MacroGenics (MGNX) United States $0.866B 0.00
LeMaitre Vascular (LMAT) United States $0.707B 33.91
PetIQ (PETQ) United States $0.694B 23.76
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.560B 0.00
Evolus (EOLS) United States $0.530B 0.00
Lantheus Holdings (LNTH) United States $0.515B 16.01
NanoString Technologies (NSTG) United States $0.413B 0.00
Cytosorbents (CTSO) United States $0.346B 0.00
BioLife Solutions (BLFS) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.335B 21.60
Quanterix (QTRX) United States $0.315B 0.00
Surface Oncology (SURF) United States $0.275B 0.00
Rockwell Medical (RMTI) United States $0.245B 0.00
Chimerix (CMRX) United States $0.202B 0.00
Fonar (FONR) United States $0.170B 10.32
Chembio Diagnostics (CEMI) United States $0.163B 0.00
Bovie Medical (BVX) United States $0.156B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.120B 0.00
Female Health (VERU) United States $0.109B 0.00
Trinity Biotech (TRIB) Ireland $0.091B 27.13
Oramed Pharmaceuticals (ORMP) Israel $0.087B 0.00
United-Guardian (UG) United States $0.086B 18.94
Neurotrope (NTRP) United States $0.077B 0.00
InfuSystems Holdings (INFU) United States $0.076B 0.00
CAS Medical Systems (CASM) United States $0.067B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Capricor Therapeutics (CAPR) United States $0.030B 0.00
Akers Biosciences Inc (AKER) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00